From: Sleep disturbance among Malaysian patients with end-stage renal disease with pruritus
Statement | N | No pruritus N = 129 N (%) | Pruritus N = 205 N (%) | P-value |
---|---|---|---|---|
Gender | ||||
 Male | 199 | 81 (40.7) | 118 (59.3) | 0.343 a |
 Female | 135 | 48 (35.6) | 87 (64.4) | |
Ethnicity | ||||
 Malay | 70 | 19 (27.1) | 51 (72.9) | 0.014* a |
 Chinese | 206 | 80 (38.8) | 126 (61.2) | |
 Indian | 58 | 30 (51.7) | 28 (48.2) | |
Age | ||||
Median age in years [IQR] |  | 58.00 [47.00–67.00] | 59.00 [49.00–68.00] | 0.558 c |
 18–30 years | 9 | 4 (44.4) | 5 (55.6) | 0.961 a |
 31–40 years | 28 | 11 (39.3) | 17 (60.7) | |
 41–50 years | 66 | 28 (42.4) | 38 (57.6) | |
 51–60 years | 85 | 32 (37.7) | 53 (62.3) | |
 61–70 years | 88 | 31 (35.2) | 57 (64.8) | |
 70 years and above | 58 | 23 (39.7) | 35 (60.3) | |
Median duration of having CKD in months [IQR] |  | 36.00 [24.00–84.00] | 60.00 [24.00–132.00] | 0.002* c |
 <  1 year | 26 | 15 (57.7) | 11 (42.3) | 0.044* a |
 1–2 years | 80 | 38 (47.5) | 42 (52.5) | |
 3–4 years | 67 | 28 (41.8) | 39 (58.2) | |
 5–6 years | 42 | 12 (28.6) | 30 (71.4) | |
 7–8 years | 33 | 12 (36.4) | 21 (63.6) | |
 9–10 years | 22 | 6 (27.3) | 16 (72.7) | |
 11 years and more | 64 | 18 (28.1) | 46 (71.9) | |
Median duration in months receiving dialysis [IQR] |  | 36.00 [12.00–60.00] | 48.00 [24.00–91.00] | 0.004* c |
 <  1 year | 33 | 21 (63.6) | 12 (36.4) | 0.009* a |
 1–2 years | 89 | 40 (44.9) | 49 (55.1) | |
 3–4 years | 77 | 28 (36.4) | 49 (63.6) | |
 5–6 years | 42 | 13 (31.0) | 29 (69.0) | |
 7–8 years | 33 | 11 (33.3) | 22 (66.7) | |
 9 years and above | 60 | 16 (26.7) | 44 (73.3) | |
Frequency of dialysis # | ||||
 Twice a week | 2 | 0 (0) | 2 (100) | 0.148 b |
 Three times a week | 332 | 129 (38.9) | 203 (61.1) | |
Presence of co-morbidities** | ||||
 Diabetes mellitus | 110 | 25 (22.8) | 85 (77.2) |  |
 Hypertension | 170 | 28 (16.5) | 142 (83.5) |  |
 Hyperlipidemia | 40 | 10 (25) | 30 (75) |  |
 Cardiovascular diseases | 6 | NA | 6 (100) |  |
 Gout | 7 | NA | 7 (100) |  |
 Goiter | 5 | NA | 5 (100) |  |